Prostate Service Line*
Explore AI apps for multiple Prostate pathologies/conditions on the Calantic platform.

Prostatic lesions Detection and characterization

Quantib Prostate* provides the user with processing, visualization, and editing of prostate MRI images. It facilitates the analysis and study review of MR data sets and provides additional mathematical and/or statistical analysis. The resulting analysis can be displayed in a variety of formats.
It includes multiparametric-MRI viewing, with the option to view images combined into a single image to support visualization. It can be used for semi-automatic segmentation of anatomical structures and provides volume computations, together with tools for manual editing. PI-RADS scoring is possible using a structured workflow1.
MRI
Prostatic lesions Detection and characterization

Prostate Intelligence* indicated for use in the assessment of MRI images of males aged 21 or over with the suspicion of prostate cancer. It has the following expected clinical benefits:
Identify patients not at risk of csPCa (clinically significant prostate cancer) through provision of a risk.
Find more significant cancer, by highlighting high-risk lesions that radiologists might miss.
Facilitating assessment and segmentation tasks through provision of candidate prostate and lesion segmentations.
Identify estimated volume of prostate and lesions.2
MRI
Extra & Prostatic lesions Detection and characterization

aPromise* is intended to be used with PSMA - PET/CT imaging. The software provides a clinical application for oncology including detection and quantification of lesion candidates in Bone, Lymph Node and Prostate3.
PET/CT
Bone metastasis Detection and characterization

aBSI* provides detection and quantification of lesions of metastatic Prostate Cancer Progression. EXINI’s aBSI mark the lesions and to quantify the disease burden - Automated Bone Scan Index (aBSI)4.
Bone scintigraphy
*Currently not available within the Calantic Viewer. Separately distributed by Bayer.
- Quantib Prostate has CE marking (CE0344) and risk class IIb. Quantib Prostate manufactured for DeepHealth by Quantib B.V.
- Prostate Intelligence has CE marking (CE0459) and risk class IIb.
- aPROMISE has CE marking (CE0123) and risk class IIa.
- aBSI has CE marking (CE0123) and risk class IIa.
- Instructions for Use Quantib Prostate, software version 2.1
- Instructions for Use Prostate Intelligence, software version 2.4
- Instructions for Use aPROMISE, software version 1.4
- Instructions for Use aBSI, software version 3.6

Request a demo and discover how to
- Centralize your AI apps on one platform
- Deploy service lines tailored to specific body regions/pathologies
- Integrate Calantic into your existing health information technology system

Prostate Service Line*

PATHOLOGY
Prostatic lesions
VENDOR

APP Quantib Prostate
DESCRIPTION
Quantib Prostate provides the user with processing, visualization, and editing of prostate MRI images. The software can be used for semi-automatic segmentation of anatomical structures and provides volume computations, together with tools for manual editing. PI-RADS scoring is possible using a structured workflow.1
MODALITY
MRI
Quantib Prostate has CE marking (CE0344) and risk class IIb.
PATHOLOGY
Prostatic/Extraprostatic lesions
VENDOR

APP aPROMISE
DESCRIPTION
aPromise is intended to be used with PSMA - PET/CT imaging. The software provides a clinical application for oncology including detection and quantification of lesion candidates (in Bone, Lymph Node and Prostate).2
MODALITY
PET/CT
aPROMISE has CE marking (CE0123) and risk class IIa.
PATHOLOGY
Extraprostatic lesions
VENDOR

APP aBSI
DESCRIPTION
aBSI provides detection and quantification of lesions for evaluation of Prostate Cancer Progression. EXINI’s aBSI mark the lesions and to quantify the disease burden - Automated Bone Scan Index (aBSI).3
MODALITY
Bone scintigraphy
aBSI has CE marking (CE0123) and risk class IIa.
*Currently not available within the Calantic Viewer. Separately distributed by Bayer.
- Instructions for Use Quantib Prostate, software version 2.1
- Instructions for Use aPROMISE, software version 1.4
- Instructions for Use aBSI, software version 3.6